The Bacillus Coagulans Market, estimated at USD 127.1 Mn in 2025, is expected to exhibit a CAGR of 8.5% and reach USD 225.0 Mn by 2032.
The market outlook remains positive, driven by growing demand for healthy, natural, and sustainable food ingredients across diverse food and beverage categories. Advances in processing, sourcing, and product innovation are enhancing quality, nutrition, and consumer appeal. Moreover, companies are strengthening their presence through innovation, strategic partnerships, and expanded distribution networks to capture new growth opportunities.
Key Development
- In 2025, Cambridge Commodities introduced ActiBio BS, a novel probiotic formulation featuring Bacillus subtilis, as a substitute for its initial ActiBio probiotic that utilizes Bacillus coagulans. This new probiotic solution offers a distinct blend of beneficial bacteria, providing consumers with a diverse range of probiotic options to support gut health and overall wellness. The introduction of ActiBio BS expands Cambridge Commodities' probiotic product line, offering customers a choice between Bacillus subtilis and Bacillus coagulans for their probiotic needs.
- In October 2025, Gutsi, a New Zealand-based company, launched a 60-day Gut Reset Kit, aiming to make high-quality, practitioner-grade supplements more accessible to consumers. This comprehensive kit is designed to support gut health and promote the overall well-being. By offering a convenient and affordable solution, Gutsi hopes to empower individuals to take control of their digestive health and experience the benefits of practitioner-recommended supplements. The launch of the Gut Reset Kit marks a significant step in making professional-grade products more widely available to the general public, allowing them to embark on a 60-day journey towards improved gut health and overall wellness.
- In September 2025, Optibac Probiotics announced the launch of its first vegan gummy supplement designed to support gut and immune health in adults. The Adult Gummies product is a mixed berry all-in-one supplement that combines the probiotic strain Bacillus coagulans Unique IS-2 with daily doses of vitamin D, zinc, and calcium.
- In 2025, Kerry Taste & Nutrition introduced a liquid version of its BC30 (Bacillus coagulans GBI-30, 6086) probiotic, making it suitable for use in plant-based and liquid milk products. This launch marks a significant milestone as it is the first commercially available liquid BC30 probiotic ingredient. BC30 is a spore-forming probiotic that can withstand heat and various manufacturing processes, making it an ideal choice for incorporation into a wide range of food and beverage products. The availability of a liquid format expands the applications of BC30, allowing food and beverage manufacturers to easily incorporate this probiotic into their formulations without compromising its stability or efficacy.
Link - https://www.coherentmarketinsights.com/market-insight/bacillus-coagulans-market-2155
Key Players: Sanzyme, Unique Biotech Limited (UBL), Zytex, Bioflex, Fengchen Group Co., Ltd, RAJVI Enterprise, Vakya life sciences, Sabinsa Corporation, Ganeden, UAS Laboratories, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., and Nebraska Culture
Contact Us